Molteni Therapeutics Receives CE Mark for Its New Product ELKOFAST® gel 0.3%

Florence, February 2018

Florence (Italy) – Molteni Therapeutics Srl announced that it received CE Mark* approval for its new product ELKOFAST^® gel 0.3%. ELKOFAST^® gel 0.3% is a non-sterile formulation of VULNOFAST^® gel, maintaining the top-level quality standards of the original product. The product is presented in easy-to-use plastic singledose containers. ELKOFAST^® gel 0.3% is a medical device intended for topical application to be used for the local treatment of skin lesions and ulcers through Photodynamic Therapy. The device is used in combination with a LED red light source at 630 nm.

* The CE Mark indicates that the product satisfies requirements of EU Directives (EU：The European Union) and all products need to be CE certified to be sold in Europe.